Yinhu Qingwen Decoction for the Treatment of Mild / Common CoVID-19
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Jiang-Rong Huang, M.D.
Yangtze University Health Science Center
Principal Investigator - Wei Zhang
Jingzhou Hospital of Traditional Chinese Medicine
Principal Investigator - Xiao-Dong Li, M.D.
Hubei Hospital of Traditional Chinese Medicine
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
3 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jingzhou Hospital of Traditional Chinese Medicine
Jingzhou, Hubei, China
- Wuhan Leishenshan (thunder God Mountain) Hospital/the First Affiliated Hospital of Dalian Medical University
Wuhan, Hubei, China
- Xiangyang Hospital of Traditional Chinese Medicine
Xiangyang, Hubei, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2021
- Primary completion
- 31 Dec 2022
- Completion
- 31 May 2023
- Last update posted
- 7 Jul 2021
- Registered enrollment
- 300
- Registry id
- NCT04278963
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.